ARCHIVES

NCI Plans Trials of Burzynski’s ‘Antineoplaston’; JAMA Report Says No Antitumor Activity In Tests

This article is from The Cancer Letter archive.

Vol. 18 No. 23 | June 5, 1992

Download PDF Visit The Full Archive

Related Articles

In Brief: Nobel Prize Awarded To Sharp, Roberts For Gene Splicing; ACS Fills Top Positions

October 22, 1993

Breslow Says NCI, Centers, States Should Collaborate On Cancer Control

June 1, 1984

Vasectomy Doesn’t Increase Prostate Cancer Risk

July 26, 2002

House Committee Aims To Cut Markup On Office-Administered Cancer Drugs.

November 16, 2001

Unwanted Distinction: MSKCC Bars Zaltrap From Formulary, Triggering Debate Over Drug Pricing

November 1, 2012

RRP Planning Dosimetry Center, Treatment Planning Projects

March 20, 1987